Early snapshot of Adverum's eye gene therapy sparks concern about vision loss

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Sep 14, 2019 at 11:42 AM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,730
    Likes Received:
    3
    via An early-stage update on Adverum Biotechnologies’ intravitreal gene therapy has triggered investor concern, after patients with wet age-related macular degeneration (AMD) saw their vision deteriorate, despite signs that the treatment is improving retinal anatomy.

    article source